{"data":[{"accessionNo":"0001950047-26-003004","issuerCik":"0001863127","issuerName":"TYRA BIOSCIENCES, INC.","ticker":"TYRA","personName":"GILLA KAPLAN","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":14295,"aggregateMarketValue":528506.16,"unitsOutstanding":53867115,"approxSaleDate":"2026-03-25","exchange":"NASDAQ","filedAt":"2026-03-25"},{"accessionNo":"0001628280-26-017387","issuerCik":"0001863127","issuerName":"Tyra Biosciences, Inc.","ticker":"TYRA","personName":"Daniel Bensen","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":8000,"aggregateMarketValue":283000,"unitsOutstanding":53372098,"approxSaleDate":"2026-03-12","exchange":"Nasdaq","filedAt":"2026-03-12"},{"accessionNo":"0001628280-26-007756","issuerCik":"0001863127","issuerName":"Tyra Biosciences, Inc.","ticker":"TYRA","personName":"Daniel Bensen","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":8000,"aggregateMarketValue":262000,"unitsOutstanding":53372098,"approxSaleDate":"2026-02-12","exchange":"Nasdaq","filedAt":"2026-02-12"},{"accessionNo":"0001628280-26-001882","issuerCik":"0001863127","issuerName":"Tyra Biosciences, Inc","ticker":"TYRA","personName":"Daniel Bensen","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":8000,"aggregateMarketValue":232000,"unitsOutstanding":53372098,"approxSaleDate":"2026-01-12","exchange":"Nasdaq","filedAt":"2026-01-12"},{"accessionNo":"0001628280-25-056777","issuerCik":"0001863127","issuerName":"Tyra Biosciences, Inc","ticker":"TYRA","personName":"Daniel Bensen","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":8000,"aggregateMarketValue":180000,"unitsOutstanding":53372098,"approxSaleDate":"2025-12-12","exchange":"Nasdaq","filedAt":"2025-12-12"},{"accessionNo":"0001628280-25-053608","issuerCik":"0001863127","issuerName":"Tyra Biosciences, Inc.","ticker":"TYRA","personName":"Alta Partners NextGen Fund II, L.P.","relationship":"Affiliate","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":256871,"aggregateMarketValue":5394291,"unitsOutstanding":53372098,"approxSaleDate":"2025-11-21","exchange":"NASDAQ","filedAt":"2025-11-21"},{"accessionNo":"0001628280-25-052968","issuerCik":"0001863127","issuerName":"Tyra Biosciences, Inc","ticker":"TYRA","personName":"Daniel Bensen","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":124589,"aggregateMarketValue":2000000,"unitsOutstanding":53372098,"approxSaleDate":"2025-11-18","exchange":"Nasdaq","filedAt":"2025-11-18"},{"accessionNo":"0001628280-25-052618","issuerCik":"0001863127","issuerName":"Tyra Biosciences, Inc","ticker":"TYRA","personName":"Daniel Bensen","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":20072,"aggregateMarketValue":320000,"unitsOutstanding":53372098,"approxSaleDate":"2025-11-17","exchange":"Nasdaq","filedAt":"2025-11-17"},{"accessionNo":"0001628280-25-052382","issuerCik":"0001863127","issuerName":"Tyra Biosciences, Inc","ticker":"TYRA","personName":"Daniel Bensen","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":86339,"aggregateMarketValue":1380000,"unitsOutstanding":53372098,"approxSaleDate":"2025-11-14","exchange":"Nasdaq","filedAt":"2025-11-14"},{"accessionNo":"0001628280-25-052140","issuerCik":"0001863127","issuerName":"Tyra Biosciences, Inc.","ticker":"TYRA","personName":"Daniel Bensen","relationship":"Officer","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":25000,"aggregateMarketValue":400000,"unitsOutstanding":53372098,"approxSaleDate":"2025-11-13","exchange":"Nasdaq","filedAt":"2025-11-13"}],"updatedAt":"2026-09-19T02:23:24.739Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data"}